Skip to content
Review Open access

Mutual Information–based Prognostic Biomarker Discovery in Cancer Genomics: Conceptual Framework and Representative Applications of MI-POG

Aug 2026 · Cancer Genomics & Proteomics · Vol 23, pp. 880 - 898 · 0 citations · 51 references
Medicine

TL;DR

MI-POG can be formalized as an information-theoretic framework for genome-wide identification of prognostic biomarkers by quantifying molecular–clinical dependencies by quantifying molecular–clinical dependencies using mutual information.

Abstract

Abstract Mutual information (MI)-based approaches have increasingly been applied to cancer genomics; however, their use for genome-wide prognostic biomarker discovery remains relatively underexplored. The present article summarizes the conceptual workflow of Mutual Information-based Prognostic Omics Gene (MI-POG) based on previously published applications in breast cancer, lower-grade glioma, and other cancer datasets. The framework consists of clinical endpoint discretization, genome-wide MI-based screening, candidate ranking, and downstream validation using conventional survival-analysis approaches. Previous MI-POG applications identified solute carrier family 20 member 1 (SLC20A1) as a prognostic biomarker in hormone receptor-positive breast cancer. Elevated SLC20A1 expression was associated with unfavorable survival outcomes and was independently validated in the Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) cohort. Methodological analyses demonstrated how survival endpoints can be integrated into an information-theoretic framework through fixed-time outcome discretization, enabling model-independent assessment of molecular–clinical dependencies. Applications across multiple cancer datasets suggested the potential applicability of the framework across biologically distinct tumor types, although further validation will be required to establish its robustness and generalizability. In conclusion, MI-POG can be formalized as an information-theoretic framework for genome-wide identification of prognostic biomarkers by quantifying molecular–clinical dependencies using mutual information. Representative applications from previously published studies suggest that MI-POG may complement conventional survival-analysis approaches and provide a useful strategy for biomarker discovery, although additional benchmarking and prospective validation will be required.

Read PDF

Similar papers

Open access Oct 2026

A Metabolic Cluster–Derived Risk Model for Prognostic Stratification, Immunometabolic Profiling, and Therapeutic Sensitivity Prediction in Prostate Cancer

This metabolic cluster–derived three-gene model may support prognostic stratification and characterization of immunometabolic heterogeneity in prostate cancer and provide a rationale for further investigation of potential treatment strategies.

Wen-Si Liu, Cong Wang, Tao Su et al. · 0 citations
Oct 2026

Mining key differentially expressed genes and construction of a prognostic risk score model for colorectal cancer based on bioinformatics.

Colorectal cancer (CRC) remains the third most common malignancy and the second leading cause of cancer-related death worldwide, with limited biomarkers available for accurate prognostic stratification. This study integrates multi-cohort transcriptomic data from four GEO datasets (GSE39582, GSE17536, GSE14333, GSE33113...

Li-Kun Liang, Han Lin, Li-Na Jun · 0 citations
Open access Sep 2026

Integrated transcriptomic and single cell analyses identify matrix stiffness-related candidate prognostic genes and epithelial dynamics in colorectal cancer

Investigation of MS-related prognostic genes and their potential biological relevance in CRC progression finds potential clues for future studies of CRC prognosis and MS-related tumor biology.

Chang-Feng Li, Hai-Hong Liu, Yao-Ping Li · 0 citations
Open access Sep 2026

Integrated Bioinformatics Identification and Multi-Dimensional Characterization of Diagnostic Hub Genes in Colorectal Cancer

These results identify seven tissue-transcriptomic candidates with strong dataset-specific discriminative performance and provide a multidimensional biological framework warranting experimental validation and prospective clinical evaluation.

Zeynep Mutlu Coskun, Muhammet Coskun, Saime Sezer Sondaş · 0 citations
Open access Jan 2026

Identification of a Novel Subtype‐Derived Prognostic Signature Based on Nucleotide Metabolism‐Related Molecular Classification for Predicting Lung Adenocarcinoma Prognosis

A subtype‐derived prognostic signature based on nucleotide metabolism‐related molecular classification with potential value for LUAD risk stratification is identified and exploratory evidence linking signature genes to tumor immune features and cellular phenotypes is provided.

Yue Shi, Shan-Shan Li, Lin Zhao et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.